Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

PureCycle Stock Tumbles 16% on $395M Capital Raise, Dilution Concerns
Markets Daniel Marsh

PureCycle Stock Tumbles 16% on $395M Capital Raise, Dilution Concerns

PureCycle Technologies shares dropped 16% after a $395 million capital raise, including 17.66 million new shares and $250 million in convertible notes, sparking dilution concerns.

PCT
Dow Rebounds on AI Buying, Hot PPI Data Keeps Fed Focus
Markets Daniel Marsh

Dow Rebounds on AI Buying, Hot PPI Data Keeps Fed Focus

The Dow Jones Industrial Average recovered 0.57% on Thursday as investors snapped up AI and chip stocks, but hotter-than-expected producer price data kept inflation and Fed rate worries alive.

INTC NVDA MU ORCL AMGN CAT VZ HON SHW
Wall Street Recovers as Chip Stocks Rally; Oracle Tumbles on Capex Shock
Markets Daniel Marsh

Wall Street Recovers as Chip Stocks Rally; Oracle Tumbles on Capex Shock

U.S. stocks rebounded Thursday as chipmakers rallied, but Oracle sank 12.5% on a $95 billion capex plan. May PPI surged 1.1%, fueling rate concerns amid Middle East tensions.

INTC NVDA MU ORCL SPY QQQ GLD USO
Pfizer Stock Rises on RBC Upgrade Despite German Drug-Pricing Threat
Markets Daniel Marsh

Pfizer Stock Rises on RBC Upgrade Despite German Drug-Pricing Threat

Pfizer shares rose 2.7% to $26.28 after RBC Capital upgraded the stock to Sector Perform, citing improved risk-reward. Meanwhile, a Reuters report flags German drug-pricing policy risks that could affect investments.

PFE LLY SPY XLV
Theriva Biologics Surges on Phase 1 Cancer Data, But Risks Remain
Markets Daniel Marsh

Theriva Biologics Surges on Phase 1 Cancer Data, But Risks Remain

TOVX surged 74.6% on Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump is not based on approval or revenue.

TOVX
Trulieve Debuts on NYSE, Launches $50M Buyback Amid Policy Shifts
Markets Daniel Marsh

Trulieve Debuts on NYSE, Launches $50M Buyback Amid Policy Shifts

Trulieve started trading on the NYSE as TRLV, authorized a $50 million buyback, and closed its first day at $11.50. Investors eye liquidity gains amid cannabis rescheduling.

Propanc Biopharma Soars After Announcing $5M Stock Buyback
Markets Daniel Marsh

Propanc Biopharma Soars After Announcing $5M Stock Buyback

Propanc Biopharma shares skyrocketed after the company authorized a $5 million stock buyback, surpassing its entire market value. Investors now watch for progress on its cancer drug PRP.

PPCB
Redwire Gains on $500M ATM Offering, Dilution Concerns Linger
Markets Daniel Marsh

Redwire Gains on $500M ATM Offering, Dilution Concerns Linger

Redwire shares jumped 8.3% Thursday after the company launched a $500 million ATM stock sale, raising $350 million already. Investors eye 2026 revenue target.

RDW
Mister Car Wash Exits Nasdaq After $3.1B LGP Buyout
Markets Daniel Marsh

Mister Car Wash Exits Nasdaq After $3.1B LGP Buyout

Mister Car Wash (MCW) completed its $3.1 billion take-private by Leonard Green & Partners, delisting from Nasdaq and cashing out public shareholders at $7.00 per share.

MCW
Quantum Cyber Drops on Dilution Fears After Drone Filament Unit Reveal
Markets Daniel Marsh

Quantum Cyber Drops on Dilution Fears After Drone Filament Unit Reveal

Quantum Cyber shares slipped after unveiling plans for a drone filament division, as a $250 million shelf registration raised dilution concerns.

Grab Stock Nears 52-Week Low as Taiwan Foodpanda Deal Faces Scrutiny
Markets Daniel Marsh

Grab Stock Nears 52-Week Low as Taiwan Foodpanda Deal Faces Scrutiny

Grab shares trade near a 52-week low of $3.26 as the $600 million foodpanda Taiwan deal awaits regulatory sign-off, despite strong Q1 growth.

GRAB
UTime Shares Surge 48% Pre-Market on Financing Deal and Web3 Ambitions
Markets Daniel Marsh

UTime Shares Surge 48% Pre-Market on Financing Deal and Web3 Ambitions

UTime shares surged 48% in pre-market trading, driven by investor focus on a $50 million financing deal and the proposed Feixiaohao Web3 acquisition, despite dilution concerns.